Evaluating the CONVIVO System for Brain Tumor Surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the diagnostic performance of the CONVIVO confocal endomicroscope in distinguishing between normal and abnormal brain tissue during surgical procedures for brain tumors. By comparing intraoperative images obtained with the CONVIVO system to conventional histologic evaluations of targeted biopsies, the researchers hope to establish a strong correlation between the two methods. The study focuses on patients with various types of brain tumors, including glioblastoma and meningiomas, who are candidates for surgical intervention. This innovative approach seeks to enhance the extent of tumor resection while minimizing risks associated with surgery.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients (age\>18)
* Adults presenting with suspected intracranial gliomas (including glioblastoma), cerebral metastasis, meningiomas, acoustic neuromas, and pituitary adenomas, who are surgical candidates
* Adults able to provide informed consent.

Exclusion Criteria:

* Pregnancy
* Children (age \<18 years)
* Fluorescein sodium (FNa) allergy

Where it's running

• Dartmouth-Hitchcock Medical Center
  Lebanon, New Hampshire, United States Recruiting

Study contacts

• Principal investigator: Linton T Evans, MD — Dartmouth-Hitchcock Medical Center
• Study coordinator: Linton T Evans, MD
• Email: Linton.T.Evans@hitchcock.org
• Phone: 603-650-5026

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Combining TIL Therapy and Pembrolizumab for Advanced Brain Cancer

  This study is testing a new treatment that combines a type of immune therapy using patients' own tumor cells with Pembrolizumab to see if it helps people with advanced brain cancer feel better and live longer.

  Recruiting Phase 1/2 Essen Biotech · Beijing, Beijing Municipality · NCT06640582

• Panitumumab-IRDye800 for guiding brain tumor surgery

  A tiny dose of panitumumab-IRDye800 is tested to see if it helps visualize brain tumors during surgery in adults.

  Recruiting Early Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07493447

• Skin closure after brain tumor surgery: running absorbable versus interrupted non-absorbable sutures

  This will test whether absorbable running intradermal sutures or non-absorbable interrupted transdermal sutures produce better wound healing after craniotomy in adults with supratentorial brain tumors.

  Recruiting Medical University of Warsaw · Warsaw, Masovian Voivodeship · NCT07413796

• Cerebrospinal fluid leak after brain tumor surgery

  This project will look at adults having planned supratentorial craniotomy for intracranial tumors to see how often cerebrospinal fluid leaks occur and what complications they cause.

  Recruiting Medical University of Warsaw · Warsaw · NCT07411690

• Pharmacoscopy-guided treatment for refractory brain tumors

  This trial tests whether personalized drug testing on a patient’s tumor cells can guide treatment choices for adults with hard-to-treat brain cancers like glioblastoma.

  Recruiting Phase 2 University of Zurich · Basel, Basel-Landschaft and 2 other locations · NCT06804655

• Effects of Salovum® and SPC® Flakes on Brain Tumor Edema

  This study is testing if eating Salovum® and SPC® flakes can help reduce swelling in the brain and improve symptoms for people with certain types of brain tumors.

  Recruiting Phase 2 Skane University Hospital · Lund · NCT06710249

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.